Article Menu

Export Article

More by Authors Links

Article Data

  • Views 1021
  • Dowloads 150

Original Research

Open Access

CMF with 5-FU in continuous infusion - a pilot study

  • F. Franchi1,*,
  • C. Pastore1
  • P. Seminara1

1Department of Clinical Medicine, University of Rome "La Sapienza", Rome, Italy

DOI: 10.12892/ejgo200602204 Vol.27,Issue 2,March 2006 pp.204-204

Published: 10 March 2006

*Corresponding Author(s): F. Franchi E-mail:

PDF (120.55 kB) View Full-text

Cite and Share

F. Franchi,C. Pastore,P. Seminara. CMF with 5-FU in continuous infusion - a pilot study. European Journal of Gynaecological Oncology. 2006. 27(2);204-204.

URL:

https://www.ejgo.net/articles/10.12892/ejgo200602204

References

[1] Bonadonna G.,V alagussa P.,M oliterni A.,Z ambetti M.,B rambilla C.:''Adjuvant cyclophospharnide,m ethotrexate,a nd fluorouracil in node positive breast cancer: the results of 20 years of follow-up". N. Engl. J. Med., 1995, 332, 901.

[2] Hansen R.M.: "5-fluorouracil by protracted venous infusion: a review of recent clinical studies". Cancer Invest., 1991, 9, 637.

[3] O'Byrne K.J., Koukourakis M.I., Saunders M.P., Salisbury A.J., Isaacs R., Varcoe S. et al.: "Cyclophosphamide, methotrexate and infusional 5-fluorouracil (infusional CMF) in metastatic breast cancer". Br. J. Cancer, 1998, 77, 1950.

[4] Mackay J., Cameron D.A., Gardiner J., Leonard T., Lee LE., Leonard R.C.: "A pilot study of infusional CMF (CMF-inf): active and well tolerated in breast cancer. The Edinburgh Breast Group". Ann. Oncol., 1996, 7, 409.

[5] Marsh J.C., Bertino J.R., Katz K.H., Davis C.A., Durivage H.J., Rome L.S. et al.: "The influence of drug interval on the effect of methotrexate and fluorouracil in the treatment of advanced colorectal cancer". J. Clin. Oncol., 1991, 9, 371.

Submission Turnaround Time

Top